Previous close | 0.2600 |
Open | 0.2500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 45.00 |
Expiry date | 2024-11-15 |
Day's range | 0.2500 - 0.3500 |
Contract range | N/A |
Volume | |
Open interest | 71 |
DEERFIELD, Ill., May 23, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 9:30 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Monday, December 2, 2024.
Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today the mission and logo for its proposed kidney care and acute therapies company, to be named Vantive.
Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.